You are in: eMedicine Specialties > Sports Medicine > Shoulder Shoulder DislocationArticle Last Updated: Nov 29, 2006AUTHOR AND EDITOR INFORMATIONAuthor: L Edward Seade, MD, Chief of Shoulder Service, Orthopaedic Specialists of Austin Coauthor(s): William Jay Bryan, MD, Clinical Professor, Department of Orthopedic Surgery, Baylor University College of Medicine; Robert Josey, MD, Consulting Staff, Department of Orthopedic Surgery, Orthopaedic Specialists of Austin Editors: Joseph P Garry, MD, Director of Sports Medicine and Sports Medicine Fellowship, Department of Family Medicine, Associate Professor of Family Medicine and Exercise & Sport Science, East Carolina University Brody School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Henry T Goitz, MD, Chief, Sports Medicine, Department of Orthopaedic Surgery, Associate Professor, Medical College of Ohio; Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Consulting Staff, Rockford Orthopedic Associates; Craig C Young, MD, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical College of Wisconsin Author and Editor Disclosure Synonyms and related keywords: dislocation of the glenohumeral joint, glenohumeral joint dislocation, dislocated shoulder, posterior shoulder dislocation, anterior shoulder dislocation, acromioclavicular joint injury, humerus, glenoid, glenohumeral ligaments, rotator cuff muscles, glenoid labrum, negative intra-articular pressure INTRODUCTIONShoulder dislocations may occur from a traumatic injury or from loose capsular ligaments. Different conditions may affect the stabilizing structures of the shoulder and, thus, negatively affect patients with shoulder dislocations. BackgroundThis article focuses on glenohumeral joint dislocation. While acromioclavicular (AC) joint separations are sometimes called shoulder dislocations by nonmedical persons, these are not true shoulder dislocations (see Acromioclavicular Joint Injury). Shoulder dislocations occur when the head of the humerus comes out of its socket, the glenoid. FrequencyUnited States
Functional AnatomyShoulder stability is maintained by the glenohumeral ligaments, the joint capsule, the rotator cuff muscles, the negative intra-articular pressure, and the bony/cartilaginous anatomy. The main stabilizers of the shoulder joint are the ligaments and the capsule complex. Multiple ligaments are present, but the inferior glenohumeral ligament is the most important and the one most commonly injured during an anterior shoulder dislocation. The injury may be a tear of the ligament/capsule off one of its bony attachments and/or it may cause a stretch injury to these structures. Tears in the rotator cuff muscles may also lead to shoulder instability. Four rotator cuff muscles are present in the shoulder. They are found superficial to the glenohumeral ligaments and the bones. Large tears may lead to shoulder instability, even with intact glenohumeral ligaments. Instability of the shoulder can also occur from injury to the nerves that control the shoulder muscles, specifically the axillary nerve. Sport Specific BiomechanicsThe shoulder is a very mobile joint; therefore, it is often placed in awkward positions during sports. Thus, the force from a fall or a blow may be sufficient to cause shoulder damage. If the force is strong enough, the athlete tears the ligaments/tendons, fractures the glenoid or humerus, and dislocates the shoulder. CLINICALHistoryPatients report a myriad of symptoms to their physician.
PhysicalThe physical examination should confirm what the clinician picked up from the history of the injury.
CausesApproximately 95% of shoulder dislocations result from a major traumatic event, and 5% result from atraumatic causes. Distinguishing the type and severity of the event is important to determine the true etiology of the dislocation. This distinction is necessary to determine the treatment. With a traumatic dislocation, the cause is obvious; however, atraumatic dislocations can result for different reasons. Ligamentous lax shoulders may dislocate with little or no trauma. Patients with lax ligaments may have 2 loose shoulders, but only 1 may be symptomatic. Congenital causes, such as excessive retroversion of the humeral head or malformation of the glenoid, can lead to instability. Neuromuscular causes, such as injury to the axillary nerve or cerebral palsy, have also been associated with shoulder instability. DIFFERENTIALSAcromioclavicular Joint Injury Bicipital Tendonitis Clavicular Injuries Rotator Cuff Injury Shoulder Dislocation Swimmer's Shoulder
|
| Drug Name | Hydrocodone and acetaminophen (Lortab, Norcet, Vicodin) |
|---|---|
| Description | Drug combination for moderate to severe pain. |
| Adult Dose | 1-2 tab or cap PO q4-6h prn |
| Pediatric Dose | <12 years: 10-15 mg/kg/dose acetaminophen PO q4-6h prn; not to exceed 2.6 g/d acetaminophen >12 years: 750 mg acetaminophen PO q4h; not to exceed 10 mg hydrocodone bitartrate per dose or 5 doses/d |
| Contraindications | Documented hypersensitivity; HACE or elevated ICP |
| Interactions | Coadministration with phenothiazines may decrease analgesic effects; toxicity increases with CNS depressants or TCAs |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Tabs contain metabisulfite, which may cause hypersensitivity; caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction |
| Drug Name | Hydrocodone and ibuprofen (Vicoprofen) |
|---|---|
| Description | Drug combination for short-term (<10 d) relief of moderate to severe acute pain. |
| Adult Dose | 1-2 tab PO q4-6h prn; not to exceed 5 tab/d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; third trimester of pregnancy |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in impaired renal function, peptic ulcer disease, impaired thyroid function, asthma, hypertension, edema, heart failure, increased ICP, and erosive gastritis; duration of action may increase in elderly persons |
| Drug Name | Acetaminophen and codeine (Tylenol With Codeine [#3]) |
|---|---|
| Description | Indicated for mild to moderate pain. |
| Adult Dose | 30-60 mg/dose based on codeine PO q4-6h or 1-2 tab q4h; not to exceed 4 g/d of acetaminophen |
| Pediatric Dose | 0.5-1 mg/kg/dose PO based on codeine q4-6h; 10-15 mg/kg/dose based on acetaminophen; not to exceed 2.6 g/d of acetaminophen |
| Contraindications | Documented hypersensitivity |
| Interactions | Toxicity of codeine increases with CNS depressants, TCAs, MAOIs, neuromuscular blockers, CNS depressants, phenothiazines, and narcotic analgesics Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity of acetaminophen |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction Hepatotoxicity with acetaminophen possible in chronic alcoholism following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; acetaminophen is contained in many OTC products, and combined use with these products may result in cumulative acetaminophen doses and exceed recommended maximum dose |
Have analgesic, anti-inflammatory, and antipyretic activities. Their mechanism of action is not known, but they may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms also may exist, such as leukotriene synthesis inhibition, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell membrane functions. During rehabilitation, shoulder discomfort may interfere with sleep or basic activities of daily living. Oral NSAIDs should decrease the discomfort. NSAIDs do not speed recovery and should not be used to accelerate physical therapy goals.
| Drug Name | Ibuprofen (Motrin, Ibuprin) |
|---|---|
| Description | DOC for mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. |
| Adult Dose | 200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d |
| Pediatric Dose | <6 months: Not established 6 months to 12 years: 4-10 mg/kg/dose PO tid/qid >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy |
| Drug Name | Naproxen (Naprosyn, Anaprox, Naprelan, Aleve) |
|---|---|
| Description | For mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which results in a decrease of prostaglandin synthesis. |
| Adult Dose | 500 mg PO followed by 250 mg q6-8h; not to exceed 1.25 g/d |
| Pediatric Dose | <2 years: Not established >2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation |
| Drug Name | Ketoprofen (Orudis, Oruvail, Actron) |
|---|---|
| Description | For mild to moderate pain and inflammation. Small initial doses are indicated in small and elderly patients and in those with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution and closely observe patient for response. |
| Adult Dose | 25-50 mg PO q6-8h prn; not to exceed 300 mg/d |
| Pediatric Dose | <3 months: Not established 3 months to 12 years: 0.1-1 mg/kg PO q6-8h >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in coagulation abnormalities or during anticoagulant therapy |
Return to play is determined when full ROM and strength have been regained. Return to play is usually sooner for older adults than for younger athletes because the fear of redislocation is much lower. Usually, older adults can return to play within 3 months. With younger adults, conditioning can continue through shoulder rehabilitation; however, decisions about returning to play should be more conservative than in older adults. Again, absolute criteria are full ROM and full strength.
When determining a patient's return to competitive sports, the author uses the following criteria:
The most common complication of an acute shoulder dislocation is recurrence. This complication occurs because the capsule and surrounding ligaments are stretched and deformed during the dislocation. Age is the most important indicator for prognosis; dislocations recur in approximately 90% of teenagers.
Another common complication following dislocation is fracture. The most common type is a Hill-Sachs lesion or compression fracture of the posterior humeral head. Fractures of the proximal humerus, greater tuberosity, coracoid, and acromion have also been described.
Rotator cuff tears also commonly occur as a result of shoulder dislocations, and the frequency of this complication increases with age. This complication can be expected in 30-35% of patients aged 40 years or older. Slow progression in return to active function following dislocation in a middle-aged patient should warrant a workup for a rotator cuff tear.
Vascular injuries are rare, but they do occur, especially in older patients. Vascular injuries are more common with inferior dislocations and usually involve a branch of the axillary artery.
Nerve injuries are much more common than vascular injuries, especially with anterior or inferior dislocations. The axillary nerve is the nerve injured most often and may be crushed between the humeral head and the axillary border of the scapula or injured by traction from the humeral head. Axillary nerve injury has been reported in as many as 33% of acute anterior dislocations.
Age at dislocation is the most important prognostic indicator for recurrence. Younger age at initial injury increases the likelihood for future dislocation. The recurrence rate is thought to be 90% if the initial episode occurs in the teen years. In patients aged 40 years or older, the recurrence rate is 10-15%. Most redislocations occur within 2 years of the primary injury. Persons with axillary nerve injuries can be expected to recover completely within 3-6 months.
Educate the patient on the importance of strength training following shoulder dislocation. The patient must understand that recurrence is possible and therapy should be used to prevent recurrence.
For excellent patient education resources, visit eMedicine's Breaks, Fractures, and Dislocations Center and Sports Injury Center. Also, see eMedicine's patient education articles, Shoulder Dislocation and Shoulder Separation.
Article Last Updated: Nov 29, 2006